Determination of a “Specific Population Who Could Benefit From Rosuvastatin”: A Secondary Analysis of a Randomized Controlled Trial to Uncover the Novel Value of Rosuvastatin for the Precise Treatment of ARDS

Background: The high heterogeneity of acute respiratory distress syndrome (ARDS) contributes to paradoxical conclusions from previous investigations of rosuvastatin for ARDS. Identification of the population (phenotype) that could benefit from rosuvastatin is a novel exploration for the precise trea...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Front Med (Lausanne)
Autores principales: Zhang, Shi, Lu, Zhonghua, Wu, Zongsheng, Xie, Jianfeng, Yang, Yi, Qiu, Haibo
Formato: Artigo
Lenguaje:Inglês
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7737567/
https://ncbi.nlm.nih.gov/pubmed/33335905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2020.598621
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares